← Leaderboards
Tina V Hartert
Vanderbilt University
$33,847,643
Attributed
$39,765,506
Total exposure
31
Grants
25
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,330,582 · 31
AHRQ$1,487,991 · 1
By mechanism
U19$24,193,274 · 12
R01$8,454,010 · 4
UG3$6,224,148 · 2
K24$1,589,015 · 1
UH3$1,172,231 · 1
K08$468,774 · 1
Top collaborators
- Leonard B Bacharier3 shared
- Thomas J Braciale3 shared
- Sarah Scheiderich Osmundson2 shared
- Ray Stokes Peebles2 shared
- Kelli K. Ryckman2 shared
- Pingsheng Wu2 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Justin H Turner$4,483,022
- Nancy Joan Brown$32,445,188
- Donald Hayes Arnold$1,593,526
- Digna R Velez Edwards$11,329,288
- Frederic Tremaine Billings$6,996,810
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaInfantChildChildhood AsthmaRespiratory Syncytial VirusChildhoodInfancyWheezingViralLower Respiratory Tract InfectionDesignFundingPredispositionLifeInfectionRecurrenceBirthRespiratory Syncytial Virus InfectionsCohortPhenotypeHypersensitivityRespiratoryImmune ResponsePathway Interactions
Grant awards (86)
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,526,298
U19 · FY2025 · AI · contact PI
ECHO Renewal for the INSPIRE Study Cohort$1,172,231
UH3 · FY2025 · OD · contact PI
Establishing critical time windows of infant RSV infection in the causal relationship of RSV and childhood asthma$767,578
R01 · FY2025 · HL
RSV and asthma: Defining host and exposure variation on disease development$584,993
U19 · FY2025 · AI · contact PI
Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core$428,548
U19 · FY2025 · AI · contact PI
ECHO Renewal for the INSPIRE Study Cohort$1,663,001
UG3 · FY2024 · OD · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,526,769
U19 · FY2024 · AI · contact PI
ECHO Renewal for the CANOE Study Cohort$1,414,688
UG3 · FY2024 · OD · contact PI
RSV and asthma: Defining host and exposure variation on disease development$1,094,138
U19 · FY2024 · AI · contact PI
Establishing critical time windows of infant RSV infection in the causal relationship of RSV and childhood asthma$779,909
R01 · FY2024 · HL
Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core$531,333
U19 · FY2024 · AI · contact PI
RSV and asthma: Defining host and exposure variation on disease development$384,835
U19 · FY2024 · AI · contact PI
ECHO Renewal for the INSPIRE Study Cohort$1,825,938
UG3 · FY2023 · OD · contact PI
ECHO Renewal for the CANOE Study Cohort$1,320,521
UG3 · FY2023 · OD · contact PI
RSV and asthma: Defining host and exposure variation on disease development$564,258
U19 · FY2023 · AI · contact PI
Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core$375,085
U19 · FY2023 · AI · contact PI
Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core$544,737
U19 · FY2022 · AI · contact PI
RSV and asthma: Defining host and exposure variation on disease development$363,713
U19 · FY2022 · AI · contact PI
Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core$426,405
U19 · FY2021 · AI · contact PI
RSV and asthma: Defining host and exposure variation on disease development$405,193
U19 · FY2021 · AI · contact PI
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development$164,815
U19 · FY2021 · AI · contact PI
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development$1,550,210
U19 · FY2020 · AI · contact PI
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development$1,505,841
U19 · FY2020 · AI · contact PI
Leukotriene modifying agents in the prevention of excess morbidity and mortality from influenza$636,629
R01 · FY2020 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$506,766
U19 · FY2020 · AI · contact PI
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development$323,535
U19 · FY2020 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$102,000
U19 · FY2020 · AI · contact PI
Leukotriene modifying agents in the prevention of excess morbidity and mortality from influenza$702,593
R01 · FY2019 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$536,192
U19 · FY2019 · AI · contact PI
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development$317,061
U19 · FY2019 · AI · contact PI
Leukotriene modifying agents in the prevention of excess morbidity and mortality from influenza$1,126,149
R01 · FY2018 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$633,052
U19 · FY2018 · AI · contact PI
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development$426,026
U19 · FY2018 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$640,703
U19 · FY2017 · AI · contact PI
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development$287,035
U19 · FY2017 · AI · contact PI
Newborn Metabolic Screening for Prediction of Childhood Respiratory Phenotypes$187,630
R21 · FY2017 · HD
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$151,509
K24 · FY2017 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$861,005
U19 · FY2016 · AI · contact PI
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development$490,568
U19 · FY2016 · AI · contact PI
Newborn Metabolic Screening for Prediction of Childhood Respiratory Phenotypes$238,860
R21 · FY2016 · HD
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$140,727
K24 · FY2016 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$578,682
U19 · FY2015 · AI · contact PI
Determinants of early childhood asthma and atopy following infant RSV infection$180,685
U19 · FY2015 · AI · contact PI
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$129,938
K24 · FY2015 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$128,431
U19 · FY2015 · AI · contact PI
Determinants of early childhood asthma and atopy following infant RSV infection$12,005
U19 · FY2015 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$1,056,724
U19 · FY2014 · AI · contact PI
Determinants of early childhood asthma and atopy following infant RSV infection$166,704
U19 · FY2014 · AI · contact PI
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$119,142
K24 · FY2014 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$1,349,783
U19 · FY2013 · AI · contact PI
Determinants of early childhood asthma and atopy following infant RSV infection$218,666
U19 · FY2013 · AI · contact PI
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$108,340
K24 · FY2013 · AI · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$2,686,487
U19 · FY2012 · AI · contact PI
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$173,831
K24 · FY2012 · AI · contact PI
Determinants of early childhood asthma and atopy following infant RSV infection$127,572
U19 · FY2012 · AI · contact PI
Tools to Reduce Infant RSV Morbidity and Asthma: Use, Adherence and Effectiveness$499,999
R01 · FY2011 · HS · contact PI
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core$433,917
U19 · FY2011 · AI · contact PI
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$173,831
K24 · FY2011 · AI · contact PI
Determinants of early childhood asthma and atopy following infant RSV infection$152,504
U19 · FY2011 · AI · contact PI
Tools to Reduce Infant RSV Morbidity and Asthma: Use, Adherence and Effectiveness$487,993
R01 · FY2010 · HS · contact PI
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$168,768
K24 · FY2010 · AI · contact PI
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$50,000
K24 · FY2010 · AI · contact PI
Tools to Reduce Infant RSV Morbidity and Asthma: Use, Adherence and Effectiveness$499,999
R01 · FY2009 · HS · contact PI
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$163,853
K24 · FY2009 · AI · contact PI
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$49,995
K24 · FY2009 · AI · contact PI
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & Asthma$159,081
K24 · FY2008 · AI · contact PI
MODIFIABLE RISK FACTORS FOR SEVERE RSV BRONCHIOLITIS$1,324
M01 · FY2008 · RR · contact PI
MEDICATION USE IN ASSESSING AND IMPROVING ASTHMA CONTROL$35
M01 · FY2008 · RR · contact PI
Dietary Antioxidants and Incidence of Adult-onset Asthma$544,485
R01 · FY2007 · AI · contact PI
Maternal and Infant Effects of Treated and Untreated Depression During Pregnancy$74,524
R03 · FY2007 · MH · contact PI
MODIFIABLE RISK FACTORS FOR SEVERE RSV BRONCHIOLITIS$28,097
M01 · FY2007 · RR · contact PI
MEDICATION USE IN ASSESSING AND IMPROVING ASTHMA CONTROL$745
M01 · FY2007 · RR · contact PI
Dietary Antioxidants and Incidence of Adult-onset Asthma$770,368
R01 · FY2006 · AI · contact PI
MODIFIABLE RISK FACTORS FOR SEVERE RSV BRONCHIOLITIS$94,801
M01 · FY2006 · RR · contact PI
Maternal and Infant Effects of Treated and Untreated Depression During Pregnancy$76,500
R03 · FY2006 · MH · contact PI
MEDICATION USE IN ASSESSING AND IMPROVING ASTHMA CONTROL$2,936
M01 · FY2006 · RR · contact PI
Dietary Antioxidants and Incidence of Adult-onset Asthma$684,020
R01 · FY2005 · AI
MEDICATION USE IN ASSESSING AND IMPROVING ASTHMA CONTROL$5,066
M01 · FY2005 · RR
Dietary Antioxidants and Incidence of Adult-onset Asthma$623,621
R01 · FY2004 · AI
The Effects of Systemic Corticosteroids on Oxidant Stress in Atopic Asthma$4,952
M01 · FY2004 · RR
Medication Use in Assessing and Improving Asthma Control$1,651
M01 · FY2004 · RR
Dietary Antioxidants and Incidence of Adult-onset Asthma$330,667
R01 · FY2003 · AI
MEDICATION USE IN ASSESSING AND IMPROVING ASTHMA CONTROL$121,149
K08 · FY2003 · AI
MEDICATION USE IN ASSESSING AND IMPROVING ASTHMA CONTROL$121,149
K08 · FY2002 · AI
MEDICATION USE IN ASSESSING AND IMPROVING ASTHMA CONTROL$121,149
K08 · FY2001 · AI
MEDICATION USE IN ASSESSING AND IMPROVING ASTHMA CONTROL$105,327
K08 · FY2000 · AI